Mundipharma
A global healthcare company with a presence across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East.
The USA-based company is developing treatments in the areas of pain management, infectious disease and consumer healthcare as well as other severe and debilitating disease areas.
Latest Mundipharma News & Features
30 January 2024
3 January 2024
23 December 2023
Today's issue
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze